Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Neoplasms
29
Tumors
26
Cancer
15
Oncology
11
44.81 neoplasms, tumors
9
Oncologie
6
therapy
6
Kanker
4
Biomarkers, Tumor
3
Medical Oncology
3
Zeitschrift
3
Antineoplastic Agents
2
Antineoplastic agents
2
Carcinogenese
2
Chemotherapy
2
Immunological aspects
2
Immunotherapy
2
Onkologie
2
Pe ́riodiques
2
Research
2
Surgery
2
Treatment
2
Tumeurs
2
Tumors in children
2
genetics
2
surgery
2
ACCIDENTES
1
ALERGIAS
1
Adolescent
1
Alimentation
1
-
11641“... of biocompatible nanocarriers that can efficiently encapsulate and deliver anticancer drug to the tumor site...”
Enlace del recurso
article -
11642
-
11643por Foglietta F, Spagnoli GC, Muraro MG, Ballestri M, Guerrini A, Ferroni C, Aluigi A, Sotgiu G, Varchi G“...-NPs-PTX was able to inhibit tumor cell viability and to induce apoptosis similarly to PTX and HSA-NPs...”
Publicado 2018
Enlace del recurso
article -
11644por Ganipineni LP, Ucakar B, Joudiou N, Bianco J, Danhier P, Zhao M, Bastiancich C, Gallez B, Danhier F, Préat V“..., as the tumors are very aggressive due to infiltration into the surrounding normal brain tissue. Even a...”
Publicado 2018
Enlace del recurso
article -
11645por Dohnert MB, Venâncio M, Possato JC, Zeferino RC, Dohnert LH, Zugno AI, De Souza CT, Paula MMS, Luciano TF“...;plusmn; 234 for interleukin 1 beta and 6.411 ± 432 for tumor necrosis factor alpha), which...”
Publicado 2012
Enlace del recurso
article -
11646“... of the blood–brain barrier (BBB) or blood–tumor barrier (BTB), preventing liposomal drugs from...”
Enlace del recurso
article -
11647“... useful information about human physiology or clinical conditions. For example, the detection of tumor...”
Enlace del recurso
article -
11648“..., IL-6, and tumor necrosis factor α. Results: As a result, we found that stent implantation...”
Enlace del recurso
article -
11649“... the circulation time and increase the drug concentration in the tumor tissue.Conclusion: These results suggested...”
Enlace del recurso
article -
11650“... between lipoplexes and LNPs. For tumor necrosis factor-α, release was mainly caused by siRNA...”
Enlace del recurso
article -
11651“..., such as interleukin 6 (IL-6), tumor necrosis factor (TNF-α) and major inflammatory mediators like cyclooxygenase...”
Enlace del recurso
article -
11652por Henri-Arthur Leroy, Ondine Strachowksi, Constantin Tuleasca, Quentin Vannod-Michel, Emilie Le Rhun, Benoit Derre, Jean-Paul Lejeune, Nicolas Reyns“.... Seventeen tumors were de novo, three were recurrences. Tumor WHO grades were II:12, III:4, IV:4. Patients...”
Publicado 2021
Enlace del recurso
article -
11653“... injected into the CAL-27 tumor-bearing mice, the DOX-AuNRs@mSiO2-HA nanoparticles could accumulate rapidly...”
Enlace del recurso
article -
11654por Shuqi Mao, Xi Yu, Yong Yang, Yuying Shan, Joseph Mugaanyi, Shengdong Wu, Caide Lu“... patients (48.3%). The preoperative factors associated with MVI were large tumor diameter (OR = 1.271, 95%CI...”
Publicado 2021
Enlace del recurso
article -
11655por Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, Robertson JD, Bhattacharya R, Mukherjee P“.... Enhancing gemcitabine delivery to the complex tumor microenvironment (TME) is a major clinical challenge...”
Publicado 2020
Enlace del recurso
article -
11656por Pei Li, Pei Li, Benlong Yang, Benlong Yang, Bingqiu Xiu, Bingqiu Xiu, Yayun Chi, Yayun Chi, Jingyan Xue, Jingyan Xue, Jiong Wu, Jiong Wu, Jiong Wu“... of current diagnostic and therapeutic modalities. Recently, researchers have found that tumor cells are more...”
Publicado 2021
Enlace del recurso
article -
11657“... that of oral PMX. Moreover, oral HP-beta-CD/PMX/DCK/P188-NE significantly suppressed tumor growth in Lewis lung...”
Enlace del recurso
article -
11658“... antibody (A-MFS) was prepared to target cells and tumor tissues highly expressing mesothelin in vitro...”
Enlace del recurso
article -
11659“... authors contributed equally to this workBackground: To solve the efficiency versus cytotoxicity and tumor...”
Enlace del recurso
article -
11660por Pereira NRC, Loiola RA, Rodrigues SF, de Oliveira CP, Büttenbender SL, Guterres SS, Pohlmann AR, Farsky SH“... or MTX-LNC treatments (started on Day 10 of GBM, every 2 days for 12 days) was quantified by tumor size...”
Publicado 2018
Enlace del recurso
article